Close

Sign in
Sign up

Menu

Data Search
Content
Startup Concierge
Newsletters
Get intel

Home
News
Antag Therapeutics raised €80m in Series A funding led by Versant Ventures, joined by Novo, SR One, Dawn Biopharma, Pictet, Longview Ventures, EIFO

Antag Therapeutics raised €80m in Series A funding led by Versant Ventures, joined by Novo, SR One, Dawn Biopharma, Pictet, Longview Ventures, EIFO

Biotech Health services

Denmark

Switzerland

United Kingdom

United States

Investments

29 November 2024

Share:

Interested in more dealflow and deeper data sets from Europe? Please consider joining Nordic 9!

Antag Therapeutics (company)

Denmark

Biotech Health services

Total investments received (USD): 91.74M

Round value (USD): 85.12M

Round investors: SR One Novo A/S EIFO Dawn Biopharma Versant Ventures Pictet Group

Company: Antag Therapeutics

Industry: Biotech Health services

Related deals

Charm Therapeutics raised $80M Series B round co-led by New Enterprise Associates and SR One, w/ OrbiMed, F-Prime Capital, Khosla Ventures, and NVIDIA

AI (big data) Biotech Health services Software Services

United Kingdom

United States

Investments 02 August 2025

Actithera to secure $75.5 million Series A financing round co-led by M Ventures, Hadean Ventures, Sofinnova Partners, and 4BIO Capital

AI (big data) Biotech Health services Software Services

Finland

Norway

France

United Kingdom

Netherlands

United States

Israel

Belgium

Investments 01 July 2025

Nuclidium in a €84M series B with Kurma Fund, Angelini Ventures, Wellington Partners, Neva SGR, DTCF, Bayern Kapital, Eurazeo, NRW and HighLight Capital

Biotech Health services Manufacturing Pharma

Switzerland

Germany

France

United Kingdom

Belgium

Italy

Japan

Investments 01 July 2025

QuNorth in an €80 million equity deal backed by EIFO and the Novo Nordisk Foundation

Electronics Hardware Manufacturing Software Services

Denmark

Investments 25 June 2025

Mosanna Therapeutics raised an $80M Series A round co-led by Pivotal bioVenture Partners and EQT, with Forbion, Broadview Ventures, and Norwest Ventures.

Biotech Health services

Switzerland

Germany

Netherlands

United States

Investments 01 June 2025

Sidebar

Verticals

Financial Services
Food Industry
Education
E-commerce
Health services
Marketplace

Benelux

Belgium
Netherlands

DACH

Austria
Germany
Switzerland

Nordics and Baltics

Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Sweden

Western Europe

France
Ireland
Italy
Portugal
Spain
United Kingdom

About
Contact
Terms of service
Privacy policy

© All rights reserved Nordic 9 2016-2025. Made with in Stockholm

Top